+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
COX-2 Selective NSAIDs Market - Global Forecast 2026-2032- Product Image
COX-2 Selective NSAIDs Market - Global Forecast 2026-2032- Product Image
Sale

COX-2 Selective NSAIDs Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011575
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The COX-2 Selective NSAIDs Market is projected to reach USD 9.15 Billion in 2026. It is expected to continue growing at a CAGR of 5.71%, reaching USD 12.78 Billion by 2032.

COX-2 Selective NSAIDs: Executive Summary

COX-2 selective nonsteroidal anti-inflammatory drugs (NSAIDs) are prescription medicines used to reduce pain and inflammation while aiming to limit some gastrointestinal effects associated with nonselective NSAIDs. Their clinical role is shaped by the balance among analgesic benefit, cardiovascular and renal risk, gastrointestinal considerations, patient comorbidities, treatment duration, and regulatory guidance. Decision-making increasingly emphasizes individualized risk assessment rather than treating the drug class as interchangeable.

Safety-Led Prescribing Is Reshaping COX-2 Selective NSAIDs

The landscape is shifting toward more cautious, indication-specific use. Clinicians increasingly assess cardiovascular disease, hypertension, kidney function, gastrointestinal history, age, concurrent antithrombotic therapy, and the shortest appropriate treatment duration before prescribing. Regulatory labeling, pharmacovigilance, generic availability, formulary controls, and the use of gastroprotective strategies also influence access and treatment choices. Clinical pathways that combine medication review, follow-up, and nonpharmacological pain management are becoming more important.

Artificial Intelligence Supports Risk Stratification and Medication Stewardship

Artificial intelligence can support COX-2 selective NSAID care by identifying contraindications, detecting potentially harmful drug combinations, summarizing longitudinal records, and helping clinicians monitor renal, cardiovascular, and gastrointestinal risk indicators. Predictive tools may also assist with follow-up prioritization and adherence review. However, implementation requires clinically validated models, representative data, transparent reasoning, privacy safeguards, and human oversight. AI should augment prescribing judgment rather than replace patient-specific assessment or established safety monitoring.

Regional Differences Reflect Regulation, Access, and Clinical Practice

North America combines strong safety oversight with broad use of electronic prescribing, medication-management programs, and evidence-based formularies. Europe emphasizes harmonized regulatory requirements, pharmacovigilance, and risk-based prescribing across diverse health systems. Asia-Pacific includes highly varied regulatory environments, aging populations, manufacturing capabilities, and access conditions. Latin America is influenced by public-sector procurement, generic medicine availability, and uneven specialist access. The Middle East shows differences between highly resourced health systems and settings with constrained access, while Africa faces additional challenges involving affordability, supply continuity, diagnostic capacity, and pharmacovigilance infrastructure.

Economic and Security Groupings Reveal Uneven Access Priorities

ASEAN markets are shaped by varied regulatory maturity, expanding healthcare capacity, and differences in medicine access across member states. BRICS countries reflect diverse approaches to domestic production, public procurement, and essential-medicine policy. The European Union benefits from coordinated regulatory structures while retaining national reimbursement and prescribing decisions. G7 health systems generally have mature safety-monitoring and clinical-guideline infrastructure. GCC countries often combine substantial healthcare investment with high reliance on imported medicines, whereas NATO members span advanced and emerging systems with differing procurement, readiness, and continuity-of-care requirements.

Country-Level Priorities Range from Stewardship to Access Expansion

Australia emphasizes evidence-based prescribing and medication safety within a universal healthcare framework. Brazil balances public-system access, generic availability, and regional inequality. Canada focuses on formulary review, safe prescribing, and provincial variation. China is strengthening regulatory oversight, domestic pharmaceutical capability, and hospital-based medication management. France, Germany, Italy, and Spain operate within European safety principles while applying distinct reimbursement, prescribing, and procurement processes. India combines a large generic medicines sector with major differences in access and monitoring. Japan and South Korea have mature regulatory systems and aging populations that heighten attention to polypharmacy and chronic disease. Mexico faces variation between public and private care. Russia’s environment reflects domestic supply priorities and healthcare-system constraints. The United Kingdom emphasizes national guidance, prescribing governance, and pharmacovigilance. The United States places strong weight on boxed warnings, cardiovascular risk assessment, formulary controls, and electronic clinical decision support.

Industry Leaders Should Build Safety-Centered, Evidence-Based Strategies

Leaders should prioritize robust post-market safety surveillance, transparent labeling, and evidence that clarifies appropriate patient selection and treatment duration. Commercial and medical teams should support clinician education on cardiovascular, renal, and gastrointestinal risk; invest in responsible digital tools that flag contraindications and interactions; and design patient materials that encourage adherence, symptom reporting, and reassessment. Access strategies should account for public procurement, generic competition, supply resilience, and local regulatory requirements. Partnerships with health systems can strengthen real-world evidence, while governance frameworks should ensure that AI-supported decisions remain auditable and clinically accountable.

Methodology Combines Clinical Evidence, Regulatory Review, and Geographic Synthesis

This executive summary uses the defined market scope of COX-2 selective NSAIDs and synthesizes established clinical, regulatory, pharmacovigilance, and healthcare-delivery considerations. The analysis compares prescribing determinants across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific, then interprets implications across ASEAN, BRICS, the European Union, the G7, the GCC, and NATO. Country coverage includes Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Russia, South Korea, Spain, the United Kingdom, and the United States. Findings are framed qualitatively and exclude market estimates, market sizing, market shares, and forecasts.

The Future of COX-2 Selective NSAIDs Depends on Disciplined Patient Selection

COX-2 selective NSAID use is increasingly defined by risk-aware clinical judgment, regulatory scrutiny, and health-system stewardship. Differences in access, monitoring, reimbursement, and supply conditions will continue to produce varied regional and national practices. Organizations that combine high-quality evidence, vigilant safety surveillance, appropriate digital support, and equitable access planning will be better positioned to use these medicines responsibly while protecting patients from avoidable harm.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. COX-2 Selective NSAIDs Market, by Route
7.1. Introduction
7.2. Injectable
7.3. Oral
7.4. Topical
8. COX-2 Selective NSAIDs Market, by Dosage Form
8.1. Introduction
8.2. Capsule
8.3. Suspension
8.4. Tablet
9. COX-2 Selective NSAIDs Market, by Product
9.1. Introduction
9.2. Celecoxib
9.3. Etoricoxib
9.4. Rofecoxib
9.5. Valdecoxib
10. COX-2 Selective NSAIDs Market, by Indication
10.1. Introduction
10.2. Ankylosing Spondylitis
10.3. Osteoarthritis
10.4. Rheumatoid Arthritis
11. COX-2 Selective NSAIDs Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.3.1. Direct Manufacturer
11.3.2. Third-Party ERetailers
11.4. Retail Pharmacy
11.4.1. Chain Pharmacy
11.4.2. Independent Pharmacy
12. COX-2 Selective NSAIDs Market, by End User
12.1. Introduction
12.2. Clinics
12.2.1. Outpatient Clinics
12.2.2. Specialty Clinics
12.3. Homecare
12.4. Hospitals
12.4.1. Private
12.4.2. Public
13. COX-2 Selective NSAIDs Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. COX-2 Selective NSAIDs Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. COX-2 Selective NSAIDs Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. AstraZeneca PLC
17.3. Bayer AG
17.4. Bristol-Myers Squibb Company
17.5. Eli Lilly and Company
17.6. GlaxoSmithKline plc
17.7. Johnson & Johnson
17.8. Merck & Co. Inc.
17.9. Novartis AG
17.10. Pfizer Inc.
17.11. Roche Holding AG
17.12. Sanofi S.A.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global COX-2 Selective NSAIDs Market, Years Considered for the Study
FIGURE 2. Global COX-2 Selective NSAIDs Market, Research Design
FIGURE 3. Global COX-2 Selective NSAIDs Market, Research Framework
FIGURE 4. Global COX-2 Selective NSAIDs Market, Data Triangulation
FIGURE 5. Global COX-2 Selective NSAIDs Market Size, 2017-2032 (USD Million)
FIGURE 6. Global COX-2 Selective NSAIDs Market Size, by Route, 2025 vs 2032 (%)
FIGURE 7. Global COX-2 Selective NSAIDs Market Size, by Route, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global COX-2 Selective NSAIDs Market Size, by Dosage Form, 2025 vs 2032 (%)
FIGURE 9. Global COX-2 Selective NSAIDs Market Size, by Dosage Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global COX-2 Selective NSAIDs Market Size, by Product, 2025 vs 2032 (%)
FIGURE 11. Global COX-2 Selective NSAIDs Market Size, by Product, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global COX-2 Selective NSAIDs Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 13. Global COX-2 Selective NSAIDs Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global COX-2 Selective NSAIDs Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global COX-2 Selective NSAIDs Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global COX-2 Selective NSAIDs Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global COX-2 Selective NSAIDs Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global COX-2 Selective NSAIDs Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global COX-2 Selective NSAIDs Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global COX-2 Selective NSAIDs Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global COX-2 Selective NSAIDs Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global COX-2 Selective NSAIDs Market Segmentation & Coverage
TABLE 2. Global COX-2 Selective NSAIDs Market Size, 2017-2032 (USD Million)
TABLE 3. Global COX-2 Selective NSAIDs Market Size, by Route, 2017-2032 (USD Million)
TABLE 4. Global Injectable Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Injectable Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Injectable Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Topical Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Topical Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Topical Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global COX-2 Selective NSAIDs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 14. Global Capsule Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Capsule Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Capsule Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Suspension Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Suspension Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Suspension Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Tablet Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Tablet Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Tablet Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global COX-2 Selective NSAIDs Market Size, by Product, 2017-2032 (USD Million)
TABLE 24. Global Celecoxib Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Celecoxib Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Celecoxib Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Etoricoxib Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Etoricoxib Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Etoricoxib Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Rofecoxib Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Rofecoxib Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Rofecoxib Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Valdecoxib Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Valdecoxib Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Valdecoxib Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global COX-2 Selective NSAIDs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 37. Global Ankylosing Spondylitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Ankylosing Spondylitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Ankylosing Spondylitis Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Osteoarthritis Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Osteoarthritis Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Osteoarthritis Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Rheumatoid Arthritis Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Rheumatoid Arthritis Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Rheumatoid Arthritis Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 47. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Direct Manufacturer Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Direct Manufacturer Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Direct Manufacturer Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Third-Party ERetailers Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Third-Party ERetailers Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Third-Party ERetailers Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Chain Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Chain Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Chain Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Independent Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Independent Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Independent Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global COX-2 Selective NSAIDs Market Size, by End User, 2017-2032 (USD Million)
TABLE 69. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Outpatient Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Outpatient Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Outpatient Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Homecare Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Homecare Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Homecare Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Private Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Private Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Private Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Public Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Public Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Public Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global COX-2 Selective NSAIDs Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific COX-2 Selective NSAIDs Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific COX-2 Selective NSAIDs Market Size, by Route, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific COX-2 Selective NSAIDs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific COX-2 Selective NSAIDs Market Size, by Product, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific COX-2 Selective NSAIDs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific COX-2 Selective NSAIDs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific COX-2 Selective NSAIDs Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific COX-2 Selective NSAIDs Market Size, by End User, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific COX-2 Selective NSAIDs Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific COX-2 Selective NSAIDs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 102. North America COX-2 Selective NSAIDs Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. North America COX-2 Selective NSAIDs Market Size, by Route, 2017-2032 (USD Million)
TABLE 104. North America COX-2 Selective NSAIDs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 105. North America COX-2 Selective NSAIDs Market Size, by Product, 2017-2032 (USD Million)
TABLE 106. North America COX-2 Selective NSAIDs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 107. North America COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 108. North America COX-2 Selective NSAIDs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 109. North America COX-2 Selective NSAIDs Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 110. North America COX-2 Selective NSAIDs Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. North America COX-2 Selective NSAIDs Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 112. North America COX-2 Selective NSAIDs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 113. Latin America COX-2 Selective NSAIDs Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Latin America COX-2 Selective NSAIDs Market Size, by Route, 2017-2032 (USD Million)
TABLE 115. Latin America COX-2 Selective NSAIDs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 116. Latin America COX-2 Selective NSAIDs Market Size, by Product, 2017-2032 (USD Million)
TABLE 117. Latin America COX-2 Selective NSAIDs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 118. Latin America COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 119. Latin America COX-2 Selective NSAIDs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 120. Latin America COX-2 Selective NSAIDs Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 121. Latin America COX-2 Selective NSAIDs Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. Latin America COX-2 Selective NSAIDs Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 123. Latin America COX-2 Selective NSAIDs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 124. Europe COX-2 Selective NSAIDs Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Europe COX-2 Selective NSAIDs Market Size, by Route, 2017-2032 (USD Million)
TABLE 126. Europe COX-2 Selective NSAIDs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 127. Europe COX-2 Selective NSAIDs Market Size, by Product, 2017-2032 (USD Million)
TABLE 128. Europe COX-2 Selective NSAIDs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 129. Europe COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 130. Europe COX-2 Selective NSAIDs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 131. Europe COX-2 Selective NSAIDs Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 132. Europe COX-2 Selective NSAIDs Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. Europe COX-2 Selective NSAIDs Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 134. Europe COX-2 Selective NSAIDs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 135. Middle East COX-2 Selective NSAIDs Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Middle East COX-2 Selective NSAIDs Market Size, by Route, 2017-2032 (USD Million)
TABLE 137. Middle East COX-2 Selective NSAIDs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 138. Middle East COX-2 Selective NSAIDs Market Size, by Product, 2017-2032 (USD Million)
TABLE 139. Middle East COX-2 Selective NSAIDs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 140. Middle East COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 141. Middle East COX-2 Selective NSAIDs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 142. Middle East COX-2 Selective NSAIDs Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 143. Middle East COX-2 Selective NSAIDs Market Size, by End User, 2017-2032 (USD Million)
TABLE 144. Middle East COX-2 Selective NSAIDs Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 145. Middle East COX-2 Selective NSAIDs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 146. Africa COX-2 Selective NSAIDs Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Africa COX-2 Selective NSAIDs Market Size, by Route, 2017-2032 (USD Million)
TABLE 148. Africa COX-2 Selective NSAIDs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 149. Africa COX-2 Selective NSAIDs Market Size, by Product, 2017-2032 (USD Million)
TABLE 150. Africa COX-2 Selective NSAIDs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 151. Africa COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 152. Africa COX-2 Selective NSAIDs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 153. Africa COX-2 Selective NSAIDs Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 154. Africa COX-2 Selective NSAIDs Market Size, by End User, 2017-2032 (USD Million)
TABLE 155. Africa COX-2 Selective NSAIDs Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 156. Africa COX-2 Selective NSAIDs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 157. Global COX-2 Selective NSAIDs Market Size, by Group, 2017-2032 (USD Million)
TABLE 158. ASEAN COX-2 Selective NSAIDs Market Size, by Group, 2017-2032 (USD Million)
TABLE 159. ASEAN COX-2 Selective NSAIDs Market Size, by Route, 2017-2032 (USD Million)
TABLE 160. ASEAN COX-2 Selective NSAIDs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 161. ASEAN COX-2 Selective NSAIDs Market Size, by Product, 2017-2032 (USD Million)
TABLE 162. ASEAN COX-2 Selective NSAIDs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 163. ASEAN COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 164. ASEAN COX-2 Selective NSAIDs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 165. ASEAN COX-2 Selective NSAIDs Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 166. ASEAN COX-2 Selective NSAIDs Market Size, by End User, 2017-2032 (USD Million)
TABLE 167. ASEAN COX-2 Selective NSAIDs Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 168. ASEAN COX-2 Selective NSAIDs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 169. GCC COX-2 Selective NSAIDs Market Size, by Group, 2017-2032 (USD Million)
TABLE 170. GCC COX-2 Selective NSAIDs Market Size, by Route, 2017-2032 (USD Million)
TABLE 171. GCC COX-2 Selective NSAIDs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 172. GCC COX-2 Selective NSAIDs Market Size, by Product, 2017-2032 (USD Million)
TABLE 173. GCC COX-2 Selective NSAIDs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 174. GCC COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 175. GCC COX-2 Selective NSAIDs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 176. GCC COX-2 Selective NSAIDs Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 177. GCC COX-2 Selective NSAIDs Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. GCC COX-2 Selective NSAIDs Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 179. GCC COX-2 Selective NSAIDs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 180. European Union COX-2 Selective NSAIDs Market Size, by Group, 2017-2032 (USD Million)
TABLE 181. European Union COX-2 Selective NSAIDs Market Size, by Route, 2017-2032 (USD Million)
TABLE 182. European Union COX-2 Selective NSAIDs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 183. European Union COX-2 Selective NSAIDs Market Size, by Product, 2017-2032 (USD Million)
TABLE 184. European Union COX-2 Selective NSAIDs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 185. European Union COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 186. European Union COX-2 Selective NSAIDs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 187. European Union COX-2 Selective NSAIDs Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 188. European Union COX-2 Selective NSAIDs Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. European Union COX-2 Selective NSAIDs Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 190. European Union COX-2 Selective NSAIDs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 191. BRICS COX-2 Selective NSAIDs Market Size, by Group, 2017-2032 (USD Million)
TABLE 192. BRICS COX-2 Selective NSAIDs Market Size, by Route, 2017-2032 (USD Million)
TABLE 193. BRICS COX-2 Selective NSAIDs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 194. BRICS COX-2 Selective NSAIDs Market Size, by Product, 2017-2032 (USD Million)
TABLE 195. BRICS COX-2 Selective NSAIDs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 196. BRICS COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 197. BRICS COX-2 Selective NSAIDs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 198. BRICS COX-2 Selective NSAIDs Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 199. BRICS COX-2 Selective NSAIDs Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. BRICS COX-2 Selective NSAIDs Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 201. BRICS COX-2 Selective NSAIDs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 202. G7 COX-2 Selective NSAIDs Market Size, by Group, 2017-2032 (USD Million)
TABLE 203. G7 COX-2 Selective NSAIDs Market Size, by Route, 2017-2032 (USD Million)
TABLE 204. G7 COX-2 Selective NSAIDs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 205. G7 COX-2 Selective NSAIDs Market Size, by Product, 2017-2032 (USD Million)
TABLE 206. G7 COX-2 Selective NSAIDs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 207. G7 COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 208. G7 COX-2 Selective NSAIDs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 209. G7 COX-2 Selective NSAIDs Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 210. G7 COX-2 Selective NSAIDs Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. G7 COX-2 Selective NSAIDs Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 212. G7 COX-2 Selective NSAIDs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 213. NATO COX-2 Selective NSAIDs Market Size, by Group, 2017-2032 (USD Million)
TABLE 214. NATO COX-2 Selective NSAIDs Market Size, by Route, 2017-2032 (USD Million)
TABLE 215. NATO COX-2 Selective NSAIDs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 216. NATO COX-2 Selective NSAIDs Market Size, by Product, 2017-2032 (USD Million)
TABLE 217. NATO COX-2 Selective NSAIDs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 218. NATO COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 219. NATO COX-2 Selective NSAIDs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 220. NATO COX-2 Selective NSAIDs Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 221. NATO COX-2 Selective NSAIDs Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. NATO COX-2 Selective NSAIDs Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 223. NATO COX-2 Selective NSAIDs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 224. Global COX-2 Selective NSAIDs Market Size, by Country, 2017-2032 (USD Million)
TABLE 225. United States COX-2 Selective NSAIDs Market Size, 2017-2032 (USD Million)
TABLE 226. United States COX-2 Selective NSAIDs Market Size, by Route, 2017-2032 (USD Million)
TABLE 227. United States COX-2 Selective NSAIDs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 228. United States COX-2 Selective NSAIDs Market Size, by Product, 2017-2032 (USD Million)
TABLE 229. United States COX-2 Selective NSAIDs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 230. United States COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 231. United States COX-2 Selective NSAIDs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 232. United States COX-2 Selective NSAIDs Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 233. United States COX-2 Selective NSAIDs Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. United States COX-2 Selective NSAIDs Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 235. United States COX-2 Selective NSAIDs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 236. Canada COX-2 Selective NSAIDs Market Size, 2017-2032 (USD Million)
TABLE 237. Canada COX-2 Selective NSAIDs Market Size, by Route, 2017-2032 (USD Million)
TABLE 238. Canada COX-2 Selective NSAIDs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 239. Canada COX-2 Selective NSAIDs Market Size, by Product, 2017-2032 (USD Million)
TABLE 240. Canada COX-2 Selective NSAIDs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 241. Canada COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 242. Canada COX-2 Selective NSAIDs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 243. Canada COX-2 Selective NSAIDs Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 244. Canada COX-2 Selective NSAIDs Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. Canada COX-2 Selective NSAIDs Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 246. Canada COX-2 Selective NSAIDs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 247. Mexico COX-2 Selective NSAIDs Market Size, 2017-2032 (USD Million)
TABLE 248. Mexico COX-2 Selective NSAIDs Market Size, by Route, 2017-2032 (USD Million)
TABLE 249. Mexico COX-2 Selective NSAIDs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 250. Mexico COX-2 Selective NSAIDs Market Size, by Product, 2017-2032 (USD Million)
TABLE 251. Mexico COX-2 Selective NSAIDs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 252. Mexico COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 253. Mexico COX-2 Selective NSAIDs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 254. Mexico COX-2 Selective NSAIDs Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 255. Mexico COX-2 Selective NSAIDs Market Size, by End User, 2017-2032 (USD Million)
TABLE 256. Mexico COX-2 Selective NSAIDs Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 257. Mexico COX-2 Selective NSAIDs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 258. Brazil COX-2 Selective NSAIDs Market Size, 2017-2032 (USD Million)
TABLE 259. Brazil COX-2 Selective NSAIDs Market Size, by Route, 2017-2032 (USD Million)
TABLE 260. Brazil COX-2 Selective NSAIDs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 261. Brazil COX-2 Selective NSAIDs Market Size, by Product, 2017-2032 (USD Million)
TABLE 262. Brazil COX-2 Selective NSAIDs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 263. Brazil COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 264. Brazil COX-2 Selective NSAIDs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 265. Brazil COX-2 Selective NSAIDs Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 266. Brazil COX-2 Selective NSAIDs Market Size, by End User, 2017-2032 (USD Million)
TABLE 267. Brazil COX-2 Selective NSAIDs Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 268. Brazil COX-2 Selective NSAIDs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 269. United Kingdom COX-2 Selective NSAIDs Market Size, 2017-2032 (USD Million)
TABLE 270. United Kingdom COX-2 Selective NSAIDs Market Size, by Route, 2017-2032 (USD Million)
TABLE 271. United Kingdom COX-2 Selective NSAIDs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 272. United Kingdom COX-2 Selective NSAIDs Market Size, by Product, 2017-2032 (USD Million)
TABLE 273. United Kingdom COX-2 Selective NSAIDs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 274. United Kingdom COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 275. United Kingdom COX-2 Selective NSAIDs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 276. United Kingdom COX-2 Selective NSAIDs Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 277. United Kingdom COX-2 Selective NSAIDs Market Size, by End User, 2017-2032 (USD Million)
TABLE 278. United Kingdom COX-2 Selective NSAIDs Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 279. United Kingdom COX-2 Selective NSAIDs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 280. Germany COX-2 Selective NSAIDs Market Size, 2017-2032 (USD Million)
TABLE 281. Germany COX-2 Selective NSAIDs Market Size, by Route, 2017-2032 (USD Million)
TABLE 282. Germany COX-2 Selective NSAIDs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 283. Germany COX-2 Selective NSAIDs Market Size, by Product, 2017-2032 (USD Million)
TABLE 284. Germany COX-2 Selective NSAIDs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 285. Germany COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 286. Germany COX-2 Selective NSAIDs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 287. Germany COX-2 Selective NSAIDs Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 288. Germany COX-2 Selective NSAIDs Market Size, by End User, 2017-2032 (USD Million)
TABLE 289. Germany COX-2 Selective NSAIDs Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 290. Germany COX-2 Selective NSAIDs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 291. France COX-2 Selective NSAIDs Market Size, 2017-2032 (USD Million)
TABLE 292. France COX-2 Selective NSAIDs Market Size, by Route, 2017-2032 (USD Million)
TABLE 293. France COX-2 Selective NSAIDs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 294. France COX-2 Selective NSAIDs Market Size, by Product, 2017-2032 (USD Million)
TABLE 295. France COX-2 Selective NSAIDs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 296. France COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 297. France COX-2 Selective NSAIDs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 298. France COX-2 Selective NSAIDs Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 299. France COX-2 Selective NSAIDs Market Size, by End User, 2017-2032 (USD Million)
TABLE 300. France COX-2 Selective NSAIDs Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 301. France COX-2 Selective NSAIDs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 302. Russia COX-2 Selective NSAIDs Market Size, 2017-2032 (USD Million)
TABLE 303. Russia COX-2 Selective NSAIDs Market Size, by Route, 2017-2032 (USD Million)
TABLE 304. Russia COX-2 Selective NSAIDs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 305. Russia COX-2 Selective NSAIDs Market Size, by Product, 2017-2032 (USD Million)
TABLE 306. Russia COX-2 Selective NSAIDs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 307. Russia COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 308. Russia COX-2 Selective NSAIDs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 309. Russia COX-2 Selective NSAIDs Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 310. Russia COX-2 Selective NSAIDs Market Size, by End User, 2017-2032 (USD Million)
TABLE 311. Russia COX-2 Selective NSAIDs Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 312. Russia COX-2 Selective NSAIDs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 313. Italy COX-2 Selective NSAIDs Market Size, 2017-2032 (USD Million)
TABLE 314. Italy COX-2 Selective NSAIDs Market Size, by Route, 2017-2032 (USD Million)
TABLE 315. Italy COX-2 Selective NSAIDs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 316. Italy COX-2 Selective NSAIDs Market Size, by Product, 2017-2032 (USD Million)
TABLE 317. Italy COX-2 Selective NSAIDs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 318. Italy COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 319. Italy COX-2 Selective NSAIDs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 320. Italy COX-2 Selective NSAIDs Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 321. Italy COX-2 Selective NSAIDs Market Size, by End User, 2017-2032 (USD Million)
TABLE 322. Italy COX-2 Selective NSAIDs Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 323. Italy COX-2 Selective NSAIDs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 324. Spain COX-2 Selective NSAIDs Market Size, 2017-2032 (USD Million)
TABLE 325. Spain COX-2 Selective NSAIDs Market Size, by Route, 2017-2032 (USD Million)
TABLE 326. Spain COX-2 Selective NSAIDs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 327. Spain COX-2 Selective NSAIDs Market Size, by Product, 2017-2032 (USD Million)
TABLE 328. Spain COX-2 Selective NSAIDs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 329. Spain COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 330. Spain COX-2 Selective NSAIDs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 331. Spain COX-2 Selective NSAIDs Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 332. Spain COX-2 Selective NSAIDs Market Size, by End User, 2017-2032 (USD Million)
TABLE 333. Spain COX-2 Selective NSAIDs Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 334. Spain COX-2 Selective NSAIDs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 335. China COX-2 Selective NSAIDs Market Size, 2017-2032 (USD Million)
TABLE 336. China COX-2 Selective NSAIDs Market Size, by Route, 2017-2032 (USD Million)
TABLE 337. China COX-2 Selective NSAIDs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 338. China COX-2 Selective NSAIDs Market Size, by Product, 2017-2032 (USD Million)
TABLE 339. China COX-2 Selective NSAIDs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 340. China COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 341. China COX-2 Selective NSAIDs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 342. China COX-2 Selective NSAIDs Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 343. China COX-2 Selective NSAIDs Market Size, by End User, 2017-2032 (USD Million)
TABLE 344. China COX-2 Selective NSAIDs Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 345. China COX-2 Selective NSAIDs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 346. India COX-2 Selective NSAIDs Market Size, 2017-2032 (USD Million)
TABLE 347. India COX-2 Selective NSAIDs Market Size, by Route, 2017-2032 (USD Million)
TABLE 348. India COX-2 Selective NSAIDs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 349. India COX-2 Selective NSAIDs Market Size, by Product, 2017-2032 (USD Million)
TABLE 350. India COX-2 Selective NSAIDs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 351. India COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 352. India COX-2 Selective NSAIDs Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 353. India COX-2 Selective NSAIDs Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 354. India COX-2 Selective NSAIDs Market Size, by End User, 2017-2032 (USD Million)
TABLE 355. India COX-2 Selective NSAIDs Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 356. India COX-2 Selective NSAIDs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 357. Japan COX-2 Selective NSAIDs Market Size, 2017-2032 (USD Million)
TABLE 358. Japan COX-2 Selective NSAIDs Market Size, by Route, 2017-2032 (USD Million)
TABLE 359. Japan COX-2 Selective NSAIDs Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 360. Japan COX-2 Selective NSAIDs Market Size, by Product, 2017-2032 (USD Million)
TABLE 361. Japan COX-2 Selective NSAIDs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 362. Japan COX-2 Selective NSAIDs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 363. Japan COX-2 Selective NSAIDs Market Size, by Online Pharmacy, 2

Companies Mentioned

  • Abbott Laboratories
  • AstraZeneca PLC
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Roche Holding AG
  • Sanofi S.A.

Related Topics

Related Reports

Non-steroidal Anti-Inflammatory Drugs (NSAIDs) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Non-steroidal Anti-Inflammatory Drugs (NSAIDs) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From
Post-Operative Pain Management Market Outlook 2026-2034: Market Share, and Growth Analysis by Drug Class (Opioids, NSAIDs, COX-2 Inhibitors, Local Anesthetics, Adjuvant Analgesics), Route of Administration, Surgery Type, Distribution Channel - Product Image

Post-Operative Pain Management Market Outlook 2026-2034: Market Share, and Growth Analysis by Drug Class (Opioids, NSAIDs, COX-2 Inhibitors, Local Anesthetics, Adjuvant Analgesics), Route of Administration, Surgery Type, Distribution Channel

  • Report
  • 160 Pages
  • Global
From
Psoriatic Arthritis Therapeutics Market Outlook 2026-2034: Market Share, and Growth Analysis by Drug Class (NSAIDs, Non-Biologic DMARDs, Biologic DMARDs, Immunosuppressants, Other Drug Classes), Route of Administration, Distribution Channel, Age Group - Product Image

Psoriatic Arthritis Therapeutics Market Outlook 2026-2034: Market Share, and Growth Analysis by Drug Class (NSAIDs, Non-Biologic DMARDs, Biologic DMARDs, Immunosuppressants, Other Drug Classes), Route of Administration, Distribution Channel, Age Group

  • Report
  • 160 Pages
  • Global
From
2025 Global Forecast for Non-Steroidal Anti-Inflammatory Drugs Market (2026-2031): High Tech Outlook Report - Product Image

2025 Global Forecast for Non-Steroidal Anti-Inflammatory Drugs Market (2026-2031): High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
2025 Global Forecast for Topical Non-Steroidal Anti-Inflammatory Drugs Market (2026-2031): High Tech Outlook Report - Product Image

2025 Global Forecast for Topical Non-Steroidal Anti-Inflammatory Drugs Market (2026-2031): High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.